Skip to main content
. Author manuscript; available in PMC: 2007 Nov 13.
Published in final edited form as: Psychiatr Genet. 2007 Apr;17(2):55–67. doi: 10.1097/YPG.0b013e328012d850

Table 2.

Primers for each DNA segment to probe possible combination of splice variants (exons a, b, c, SEC, and VASE), as well as for an exon outside of the splice sites for measuring total NCAM1

Primer Forward Reverse
VASE 5′-GACCCCATTCCCTCCAT CAC-3′ 5′-GGCTACGCACCAC CATGTG-3′
Exon a 5′-GACGCAGCCAGTCCA TAGC-3′ a
Exon b 5′-CGTCTACCCCTGTTC CATTGTC-3′ 5′-TCTGGTGGAGACAATG GAACAG-3′
Exon c 5′-TCCTGCCCTTGCAACCA 3′ 5′-GGTTGCAAGGGCAG GAAGA-3′
SEC exon 5′-CCAAGCTGGTCTTCA TAATGCTCTA-3′ 5′-TTTGATGCTTGAACACTAT GAACATG-3′
Exon 3 5′-GGCGGCGCTCAATGG-3′ b
Exon 8 c 5′-GATCAGGTTCACTTTAATA GAGTTTCCA-3′
SNP9 for sequencing 5′-CGCAGCCAGTCCGTAAG TAAAG-3′ 5′-AAGCTGGACCGGCTAC TAGGA-3′

The numbering is shown in Fig. 1 according to accession M22094. SNP 9 was also genotyped by direct sequencing.

NCAM1, neural cell adhesion molecule 1; VASE, variable alternative spliced exon.

a

Only the forward primer could be designed because exon a is 14 bp.

b

Exon 3 is before the variable exons and only the forward primer was needed to PCR outside the exons. The reverse primer was designed within another exon.

c

Exon 8 is after the variable exons and only the reverse primer was needed to PCR outside the exons. The forward primer was designed within another exon.